Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2023-06-30
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There are many screening questionnaires for eating disorders in the literature, but we note the absence of a specific and validated tool for their screening during pregnancy, which would make it possible to differentiate maternal dietary concerns related to pregnancy from symptoms linked to a proven eating disorder.
The main objective of the study is to evaluate which items of the Sick Control One stone Fat Food (SCOFF-F) and Eating disorders examination questionnaire (EDE-Q) questionnaires could be specific to an ED during pregnancy and not related to the simple state of pregnancy, by comparing the answers of pregnant women, for whom the diagnosis of ED has been made, to those of pregnant women without an ED.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Detection of Patients with Eating Disorders in General Practice
NCT06595381
EXPert System, ALImentary
NCT03208699
Overview of Knowledge and Practices Among Healthcare Professionals Treating Eating Disorders
NCT07339826
A Single Session Self-guided Acceptance-based Digital Intervention Targeting Food Cravings in Pregnancy
NCT06129461
Transversal, Controlled and Not Randomized Study, Laying on the Desire of Children and Eating Disorders in a Population of Infertile Women
NCT02029365
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group of pregnant women with eating disorder
Administration of the SCOFF-F and EDE-Q questionnaires
The participants will answer to the SCOFF-F and EDE-Q questionnaires as well as socio-demographic questions
Group of pregnant women with no eating disorder
Administration of the SCOFF-F and EDE-Q questionnaires
The participants will answer to the SCOFF-F and EDE-Q questionnaires as well as socio-demographic questions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Administration of the SCOFF-F and EDE-Q questionnaires
The participants will answer to the SCOFF-F and EDE-Q questionnaires as well as socio-demographic questions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Woman with current diagnosed Eating Disorders or without Eating Disorders
* Having a good command of the French language
* Having given their consent for their participation in the research
Exclusion Criteria
* Woman who does not have a good command of the French language.
* Woman with past Eating Disorders
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Henri Laborit
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Henri Laborit
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Charlotte XAVIER-DAVID, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A00529-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.